← Open Payments lookup

AMY LEWING: Open Payments

NPI 1508481953 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,553 in 75 payments from 16 companies in 2025. Trend: 2023 $2,176 · 2024 $1,220 · 2025 $1,553

Food & beverage: $1,544Education: $9
CompanyPaymentsAmount
Janssen Biotech, Inc.13$289
Ardelyx, Inc.12$273
ABBVIE INC.17$241
Takeda Pharmaceuticals U.S.A., Inc.8$149
Madrigal Pharmaceuticals2$133
Gilead Sciences, Inc.4$93
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$81
GENZYME CORPORATION2$76
Phathom Pharmaceuticals, Inc.5$70
Janssen Scientific Affairs, LLC1$45

Products named: TREMFYA, IBSRELA, ENTYVIO, REZDIFFRA, RINVOQ, SKYRIZI, XIFAXAN, DUPIXENT.

Industry payments across LA — which companies pay providers there.